Medtronic plc – Double-digit growth in emerging market led to growth in FY19

in , on October 17, 2019

Medtronic’s revenues increased by 2% to $30.56bn for FY19, which was below our guidance of $31.15bn for FY19. Revenues in Q4FY19 increased by $2mn to $8.14bn which adjusts for a $289mn negative impact from foreign currency

No. of Pages – 44


Executive Summary

Financial Statements

–Income Statement and Forecast

–Balance Sheet

–Cash Flow

–Q4FY19 & FY19 Results – Overview

–Q4FY19 & FY19  – Segment  Performance

–FY20 Guidance


–GAAP to Non-GAAP Reconciliation

Historical Performance

–Key Ratios

–Profitability Ratios, Asset Turnover Ratio, Growth Ratio

–Per Share Items and Key Ratios

–Key Cash Flow Items

–P/E Band

Product Performance and Key Developments



–Key Developments

Valuation and Consensus Performance

–Relative Valuation

–Analyst Recommendations

  • Market Price Performance

Release Information

  • Released

    October 17, 2019

  • Last Updated

    February 17, 2020